P659-1174 Screening compound: 1-{[5-methyl-7-(pyrrolidin-1-yl)-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl]methyl}-4-(pyridin-2-yl)piperazine

P659-1174 Screening compound: 1-{[5-methyl-7-(pyrrolidin-1-yl)-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl]methyl}-4-(pyridin-2-yl)piperazine
P659-1174 Screening compound: 1-{[5-methyl-7-(pyrrolidin-1-yl)-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl]methyl}-4-(pyridin-2-yl)piperazine alternative view

Chemical Structure Depiction of ChemDiv screening compound P659-1174
1-{[5-methyl-7-(pyrrolidin-1-yl)-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl]methyl}-4-(pyridin-2-yl)piperazine

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

P659-1174

Molecular Formula

C20H26N8 (C20 H26 N8)

Compound Name

1-{[5-methyl-7-(pyrrolidin-1-yl)-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl]methyl}-4-(pyridin-2-yl)piperazine

IUPAC name

1-{[5-methyl-7-(pyrrolidin-1-yl)-[124]triazolo[15-a]pyrimidin-2-yl]methyl}-4-(pyridin-2-yl)piperazine

SMILES

Cc1nc2nc(CN(CC3)CCN3c3ncccc3)nn2c(N2CCCC2)c1

InChI

InChI=1S/C20H26N8/c1-16-14-19(27-8-4-5-9-27)28-20(22-16)23-17(24-28)15-25-10-12-26(13-11-25)18-6-2-3-7-21-18/h2-3,6-7,14H,4-5,8-13,15H2,1H3

InChI Key

FHMCDTPGIWTJEO-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27609785

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

378.48

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

4.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

2.315

Distribution Coefficient, logD

2.285

Water Solubility, LogSw

-2.16

Polar Surface Area

50.249

Acid Dissociation Constant (pKa)

23.63

Base Dissociation Constant (pKb)

6.26

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

50.00

P659-1174 in Drug Discovery

Included in Screening Libraries

GPCR Targeted Library (31838 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

SmartTM Library (51161 compounds)

Targeted Diversity Library (40567 compounds)

Epigenetics Focused Set (26518 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
Targets:
  • GPCR
  • Proteases
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with P659-1174 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound P659-1174?
Check Price and Availability of P659-1174, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of P659-1174 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for P659-1174
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for P659-1174
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of P659-1174 available by request